What checks need to be done before getting an Insulin pump?

DTN UK, which is a diabetes technology network, would recommend for patients to have three things. Patients should need to have an up-to-date psychological review, which essentially means they need not to have any mental health issues. Number two, patients should have been screened for celiac disease, right? So patients would have seen, I think Donna would probably be able to answer it, what kind of precautions and diet need to be taken in patients with celiac. And number three would be that they need to have an up-to-date retinopathy screen to exclude any proliferative retinopathy. Because with insulin pumps, if you're able to control the blood sugar suddenly, but it can aggravate the eye condition. So three things, CELAC screen, retinopathy screen, and number three, up-to-date psychological mental health review, if it's necessary. Donna, any comments on the CELAC screen? Not specifically, but I think at the end of the day, which is important is the success of a pump therapy or regime is as successful as the user gives input into the pump and I think that's also a very important thing to educate the patients as well as not to expect that a pump is sort of all automated but that they do have input and and the input is very important to have a successful pump therapy glycemic control, the input from the user itself. But yes, with regards to celiac disease and some other conditions, such as, you know, even gastroparesis or even cystic fibrosis, we'd manage in different ways for absorption of glucose and we would use different features on the pump, specifically with certain aspects, but nothing further particularly to that. And I would, I would reiterate what Donna has said that instant pump is a tool and is as good as the person who's using the pump. So educating the person who's using the pump is crucial, and it's not an autonomous device is actually involves much more self-engagement that's that's required as part of MDI therapy. And most of the pumps are not autonomous enough yet to take over the function on their own. And a huge amount of patient engagement is necessary to get the most out of the pump. And on the other extreme if patients are, patient selection has to be robust. And we are very careful about offering pump therapy to only patients that we're convinced as a specialist team will get the most out of it and discourage people who were not entirely convinced would get benefit from pharma therapy.